Synthesis and preliminary pharmacology of a novel butyrophenone derivative, ID-4708.
D000818:Animals; D001058:Apomorphine / Q000037:antagonists & inhibitors; D001362:Avoidance Learning / Q000187:drug effects; D001522:Behavior, Animal / Q000187:drug effects; D002090:Butyrophenones / Q000138:chemical synthesis* / Q000494:pharmacology / Q000633:toxicity; D002375:Catalepsy / Q000139:chemically induced; D002415:Cats; D002746:Chlorpromazine / Q000494:pharmacology; D004353:Drug Evaluation, Preclinical; D004357:Drug Synergism; D004569:Electroencephalography; D004837:Epinephrine / Q000037:antagonists & inhibitors; D006220:Haloperidol / Q000494:pharmacology; D006591:Hexobarbital / Q000494:pharmacology; D006801:Humans; D006845:Hydrocarbons, Fluorinated / Q000138:chemical synthesis / Q000494:pharmacology / Q000633:toxicity; D007099:Imipramine / Q000037:antagonists & inhibitors; D007928:Lethal Dose 50; D008297:Male; D008694:Methamphetamine / Q000494:pharmacology; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D010146:Pain / Q000188:drug therapy; D010880:Piperidines / Q000138:chemical synthesis* / Q000494:pharmacology / Q000633:toxicity; D051381:Rats; D014272:Trifluperidol / Q000494:pharmacology
D002090:Butyrophenones; D006845:Hydrocarbons, Fluorinated; D010880:Piperidines; D008694:Methamphetamine; D006591:Hexobarbital; D006220:Haloperidol; D001058:Apomorphine; D007099:Imipramine; D014272:Trifluperidol; D002746:Chlorpromazine; D004837:Epinephrine